Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, commercial and real world insights into outcomes to address modern market realities. We bring together a talented team of professionals with a deep understanding of patient and physician behaviors and market dynamics. Together we share diverse insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. Syneos Health is powered by an authentic, inclusive and high-performance culture that cares for colleagues, customers, patients, communities and the environment.
Syneos Health의 시장 확장을 추적하고 있습니다
신규 마케팅 및 PR 활동 — 새 시그널 17건이 방금 나타났습니다.
Syneos Health의 글로벌 확장이 경쟁사와 비교해 어떤지
Syneos Health본 회사막대는 비교 대상 회사 간 상대적 규모를 나타냅니다.
열5| 회사 | 시장 | 신규 시장 | 모멘텀 | 활동 | 확장 점수 |
|---|---|---|---|---|---|
 Syneos Health본 회사 | 0 | 0 | — | 0 | 0 |
Bus Proc & Perf Analyst
공고 보기Buenos Aires, Buenos Aires Province, Argentina · 그저께
L&D Trainer
공고 보기Buenos Aires, Buenos Aires Province, Argentina · 그저께
Clinical Support Specialist
공고 보기Buenos Aires, Buenos Aires Province, Argentina · 그저께
Incretins. CKM therapies. Combination treatments. Cardiometabolic innovation is advancing rapidly—but complexity is growing just as fast.Discover how our cross-therapeutic model helps sponsors accelerate development in cardiovascular, metabolic and renal programs with greater clarity and speed to market. ...
종료됨
The future of cardiometabolic drug development depends on seeing the full picture.Risk doesn't develop in silos and neither should our development strategies.As we head into ADA 2026, I share perspectives on why approaching cardiometabolic disease as an interconnected continuum may help reshape how we think about trial design, risk management and long-term patient outcomes.Read more: Rethinking Risk, Improving Outcomes in Cardiometabolic Drug Development https://lnkd.in/ePUtrRs3If you will be at ...
종료됨
Two incredible days of conversations recorded live from the Syneos Health Early Signals podcast booth on the ASCO conference floor 🎙️Over the past 48 hours, I’ve had the opportunity to sit down with leaders across oncology, precision medicine, cell therapy and drug development to discuss the innovations, challenges and breakthroughs shaping what comes next for patients.These are just some of the conversations from the last two days at ASCO, and I’m incredibly grateful to Diana Chen, Nick Glover ...
종료됨Veeva Systems의 Vault EDC가 1000개 이상의 시험을 지원하며, 상위 20개 바이오제약 기업 중 8개사가 표준화하여 임상 데이터 관리 효율성 향상.
Telix Pharmaceuticals는 2026년 5월 11일부터 David Gill을 사외이사로 임명하며, 향후 회장 취임 예정. Gill은 35년 이상의 생명과학 경험 보유.
Crossject가 Syneos Health와 제휴하여 무침 자동 주사기 기술을 사용한 응급 간질 치료제 ZEPIZURE의 미국 상업 출시를 진행합니다.
인증된 이메일과 직통 전화 잠금 해제
무료 · 신용카드 불필요
Syneos Health의 사업, 시장, 성장 시그널에 대한 빠른 답변입니다.
© 2026 Pubrio. 모든 권리 보유.
